| Symbol | IMUC |
|---|---|
| Name | EOM PHARMACEUTICAL HOLDINGS INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 07645 United States NJ 136 Summit Avenue Suite 100 |
| Telephone | +1 201-351-0605 |
| Fax | — |
| — | |
| Website | http://www.eompharma.com |
| Incorporation | US |
| Incorporated On | 1987 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Forvis Mazars, LLP; |
| Audit Status | UNAUDITED |
| Reporting Status | Alternative Reporting Standard |
| CIK | 0000822411 |
| Description | The Company is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Our development pipeline consists of multiple programs and clinical indications at various stages of development. Our portfolio currently consists of two product candidates: EOM613 and EOM147. Additional info from OTC: |